ArticleActa pharmacologica Sinica2026

RNF6 activates the AKT/mTOR signaling pathway by inhibiting PTEN via K27-linked polyubiquitination in myeloma.

Yue-Ya Zhong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.